Our findings of PSMA PET association with HOXB13 could pave the way for future studies incorporating HOXB13 and PSMA testing at earlier stages of PC diagnosis, which could then guide personalized PC care. This evidence concerns the gene FOLH1 and pachyonychia congenita.